JAC Advance Access originally published online on November 16, 2004
Journal of Antimicrobial Chemotherapy 2004 54(6):971-981; doi:10.1093/jac/dkh474
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JAC vol.54 no.6 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved
Review |
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy
1 Department of Microbiology, Queen Elizabeth Hospital, Birmingham; 2 Department of Microbiology, Papworth Hospital, Cambridge; 3 Department of Microbiology, Freeman Hospital, Newcastle-upon-Tyne; 4 Department of Medical Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
* Corresponding author and Chair of the Working Party. Tel: +44-191-233-6161; Fax: +44-191-223-1224; Email: kate.gould{at}tfh.nuth.northy.nhs.uk
The BSAC Guidelines on Endocarditis were last published in 1998. The Guidelines presented here have been updated and extended to reflect changes in both the antibiotic resistance characteristics of causative organisms and the availability of new antibiotics. Randomized, controlled trials suitable for the development of evidenced-based guidelines in this area are still lacking, and therefore a consensus approach has again been adopted. The Guidelines cover diagnosis and laboratory testing, suitable antibiotic regimens and causative organisms. Special emphasis is placed on common causes of endocarditis, such as streptococci and staphylococci, however, other bacterial causes (such as enterococci, HACEK organisms, Coxiella and Bartonella) and fungi are considered. The special circumstances of prosthetic endocarditis are discussed.
Keywords: antibiotic therapy , guidelines , endocarditis , BSAC
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Bathoorn, M. A. Heitbrink, C. L. A. Reichert, and W. G. Boersma A turbulent cause of bilateral pneumonia Eur. Respir. J., June 1, 2009; 33(6): 1513 - 1516. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Leibovici, L. Vidal, and M. Paul Aminoglycoside drugs in clinical practice: an evidence-based approach J. Antimicrob. Chemother., February 1, 2009; 63(2): 246 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. McLellan and D. Partridge Prosthetic valve endocarditis caused by Pseudomonas mosselii J. Med. Microbiol., January 1, 2009; 58(1): 144 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. J. Brown, R. Hope, D. M. Livermore, G. Brick, K. Broughton, R. C. George, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06 J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii75 - ii85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Livermore Future directions with daptomycin J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii41 - iii49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Andrews and for the BSAC Working Party on Susceptibility Testi BSAC standardized disc susceptibility testing method (version 7) J. Antimicrob. Chemother., August 1, 2008; 62(2): 256 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. O. Helgason, A. H. Thomson, and C. Ferguson A review of vancomycin therapeutic drug monitoring recommendations in Scotland J. Antimicrob. Chemother., June 1, 2008; 61(6): 1398 - 1399. [Full Text] [PDF]
|
|
|
|
|
|
B. C. Millar, B. D. Prendergast, and J. E. Moore Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis J. Antimicrob. Chemother., January 1, 2008; 61(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yung, D. Kottachchi, B. Neupane, S. Haider, and M. Loeb Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review J. Antimicrob. Chemother., November 1, 2007; 60(5): 921 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Andrews and for the BSAC Working Party on Susceptibility Testi BSAC standardized disc susceptibility testing method (version 6) J. Antimicrob. Chemother., July 1, 2007; 60(1): 20 - 41. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P Beynon, V K Bahl, and B. D Prendergast Infective endocarditis BMJ, August 12, 2006; 333(7563): 334 - 339. [Full Text] [PDF]
|
|
|
|
 |
|
 B D Prendergast The changing face of infective endocarditis Heart, July 1, 2006; 92(7): 879 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. M. Verhagen, A. C. Vedder, P. Speelman, and J. T. M. van der Meer Antimicrobial treatment of infective endocarditis caused by viridans streptococci highly susceptible to penicillin: historic overview and future considerations J. Antimicrob. Chemother., May 1, 2006; 57(5): 819 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Gemmell, D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgway, R. E. Warren, and on behalf of the Joint Working Party of the Britis Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK J. Antimicrob. Chemother., April 1, 2006; 57(4): 589 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Shah Comment on: Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy J. Antimicrob. Chemother., August 1, 2005; 56(2): 432 - 432. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Perry and on behalf of the Working Party of the British Soci Endocarditis guidelines: authors' response J. Antimicrob. Chemother., August 1, 2005; 56(2): 432 - 433. [Full Text] [PDF]
|
|